Navigation Links
Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45%
Date:11/5/2009

of developing, producing and selling OPAXIO, pixantrone, and brostallicin, and the risk factors listed or described from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, we do not intend to update or alter our forward-looking statements whether as a result of new information, future events, or otherwise.

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: deramian@ctiseattle.com
    www.celltherapeutics.com/media.htm

    Investors Contact:
    Ed Bell
    T: 206.282.7100
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors.htm
                               Cell Therapeutics, Inc.
                   Condensed Consolidated Statements of Operations
                      (In thousands, except per share amounts)
                                     (unaudited)


                                  Three Months Ended     Nine Months Ended
                                    September 30,          September 30,
                                    -------------          -------------
                                  2009          2008      2009       2008
                                  ----          ----      ----       ----
    Revenues:
      Product sales                 $-        $2,580        $-     $8,824
      License and contract revenue  20            20        60         60
                                   ---           ---       ---        ---
        Total revenues              20         2,600        60      8,884
                                   ---         -----       ---     
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... Ticket Down is a reputable source for authentic tickets ... Deadheads have been anxiously anticipating this blockbuster weekend ever since ... 50 years ago back in the 60s in Palo Alto, ... death of Jerry Garcia in 1995. This beloved group ... bluegrass, folk, space rock and country to become an unforgettable ...
(Date:3/1/2015)... Indiana Fiber Network, LLC (IFN), the ... Networking, LLC (NewWays) selected IFN as primary fiber ... is well positioned to scale future backbone transport ... in rural parts of Indiana,” said Scott Reed, ... IFN Enterprise Sales Manager, IFN provides NewWays fiber ...
(Date:3/1/2015)... 2015 “ The Barrel Mill ” was ... which takes a look at the latest and coolest technology ... of NewsWatch and a technology expert, conducted the review and ... to drinks. , According to Home Distillation of Alcohol, it's ... Well, there’s a pretty cool product that’ll help anyone achieve ...
(Date:3/1/2015)... 28, 2015 CrossFit Attollo is a CrossFit ... offering a special discount to new members. Now through ... a three month contract will receive their fourth month half ... cost members $440. The three month contract is only ... then the fourth month comes in at only $55. The ...
(Date:2/28/2015)... 2015 In recent years Medical Marijuana has ... physicians as a way for them to expand their patient ... as medicine. Since the FDA still lists Cannabis as a ... to licensed physicians that can help guide them when ... Malka in Santa Cruz, CA is a leader in ...
Breaking Medicine News(10 mins):Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2
... the lungs in bar workers according to a new study//. ... of the American Medical Association, and comes from Scotland where ... banned on March 26, 2006. ,Researchers such ... in Dundee, Scotland took this opportunity to study 77 nonsmoking ...
... of colon cancer (carcinoma) cases has been discovered by ... which could be the possible target for treatment against ... were able to rescue zebra fish from the effects ... gene, by genetically disabling (undoing) a molecule called C-Terminal ...
... "Mediterranean" diet rich in olive oil, vegetables, fruits, legumes, ... Alzheimer's disease according to U.S. researchers. ,Lead researcher ... Columbia University Medical Center in New York said, "We ... Alzheimer's disease." ,Scarmeas added that this benefit ...
... Dr Mukesh Haikerwal, said today the Government must make ... to be truly effective in meeting the needs of ... were announced today by the Prime Minister, and the ... care. ,While the AMA is generally pleased ...
... for permission with European medicine regulators to begin selling its ... move in the US last month, and comes slightly earlier ... to be one of GSK's most promising pipeline drugs as ... Code the sales of the drug could cross 2 bln ...
... under go lumpectomy feel that the outcome is a ... look, a recent survey has revealed. , ,The ... 2006 conference in San Francisco was witness to the ... of unhappy lumpectomy patients would explore the possibility of ...
Cached Medicine News:Health News:Novel Techniques to Tackle Colon Cancer 2Health News:Mental Health Package Regrettably Undervalues the Role of the GP 2
(Date:2/26/2015)...  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... 2014 financial results after the market closes on Thursday, ... Company will host a conference call with the investment community ... March 5, 2015 to discuss the results of the ... access the live conference call via telephone by dialing (877) ...
(Date:2/26/2015)... -- Mail-service and specialty pharmacies will save ... plans $23.3 billion over the next decade, according ... Association (PCMA). "Home delivery of traditional ... ways to reduce health costs," said PCMA President ... resist efforts to restrict these cost-saving tools." ...
(Date:2/26/2015)... Every year many millions of donations are ... Nevertheless, year after year doctors and the medical profession ... test to determine the status of heart health in ... even though that technology is over 100 years old, ... know, (while most patients do not know) that EKG,s, ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2
... BOSTON, Sept. 26, 2011 Not for release, ... Australia, South Africa, Japan or any jurisdiction where to do so would ... 26 September 2011CASH OFFER BY ALERE ... A WHOLLY-OWNED SUBSIDIARY OF ALERE INC. ("ALERE") FOR ...
... and LACHEN, Switzerland, Sept. 26, 2011 ... human protein products manufacturers in the world, has launched ... and safety of wilate® (von Willebrand Factor/Factor ... bleeding in pediatric and adult patients with Type 3 ...
Cached Medicine Technology:Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 2Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 3Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 4Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 5Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 6Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 7Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 8Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 9Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 10Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 11Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 12Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 13Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 14Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 2Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 3
MBP's equivalent to the "Universal Yellow" tip, this 200 ul tip utilizes a MicroPoint design for accurate sample handling. 10 L Ref. mark....
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels - Ideal for use with CastAway System...
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
Medicine Products: